{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:27:46Z","timestamp":1759336066443,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"am","delay-in-days":337,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000646","name":"JSPS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["19K17727","20K09423","22K15021"],"award-info":[{"award-number":["19K17727","20K09423","22K15021"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004420","name":"Wakayama Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004420","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18nk0101390h"],"award-info":[{"award-number":["JP18nk0101390h"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.peptides.2023.171146","type":"journal-article","created":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T11:40:26Z","timestamp":1703677226000},"page":"171146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Vascular endothelial cell-specific overexpression of CNP did not improve liver fibrosis in HFFCD-induced NASH, but did improve renal lesions"],"prefix":"10.1016","volume":"172","author":[{"given":"Takuya","family":"Ensho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Hino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikiya","family":"Miyazato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Iwakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.peptides.2023.171146_bib1","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.peptides.2023.171146_bib2","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1542-3565(04)00440-9","article-title":"Nonalcoholic fatty liver disease: a review of current understanding and future impact","volume":"2","author":"Charlton","year":"2004","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"Suppl 1","key":"10.1016\/j.peptides.2023.171146_bib3","first-page":"S5","article-title":"The epidemiology of nonalcoholic fatty liver disease in adults","volume":"40","author":"Clark","year":"2006","journal-title":"J. Clin. Gastroenterol."},{"issue":"1","key":"10.1016\/j.peptides.2023.171146_bib4","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.22603","article-title":"Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management","volume":"49","author":"Vuppalanchi","year":"2009","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.peptides.2023.171146_bib5","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00535-021-01796-x","article-title":"Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis 2020","volume":"56","author":"Tokushige","year":"2021","journal-title":"J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.peptides.2023.171146_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1210\/er.2005-0014","article-title":"Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions","volume":"27","author":"Potter","year":"2006","journal-title":"Endocr. Rev."},{"issue":"2","key":"10.1016\/j.peptides.2023.171146_bib7","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1152\/physrev.00022.2015","article-title":"Molecular physiology of membrane guanylyl cyclase receptors","volume":"96","author":"Kuhn","year":"2016","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.peptides.2023.171146_bib8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0006-291X(84)91077-5","article-title":"Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP)","volume":"118","author":"Kangawa","year":"1984","journal-title":"Biochem Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.peptides.2023.171146_bib9","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0006-291X(88)80557-6","article-title":"The presence of brain natriuretic peptide of 12,000 daltons in porcine heart","volume":"155","author":"Minamino","year":"1988","journal-title":"Biochem Biophys. Res. Commun."},{"issue":"23","key":"10.1016\/j.peptides.2023.171146_bib10","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.1073\/pnas.81.23.7661","article-title":"Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle","volume":"81","author":"Winquist","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6210","key":"10.1016\/j.peptides.2023.171146_bib11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/338078a0","article-title":"A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor","volume":"338","author":"Chinkers","year":"1989","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.peptides.2023.171146_bib12","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1210\/endo-129-2-1104","article-title":"C-type natriuretic peptide (CNP) in rats and humans","volume":"129","author":"Komatsu","year":"1991","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.peptides.2023.171146_bib13","first-page":"217","article-title":"The natriuretic peptide system in the brain: implications in the central control of cardiovascular and neuroendocrine functions","volume":"13","author":"Imura","year":"1992","journal-title":"Front Neuroendocr."},{"issue":"3","key":"10.1016\/j.peptides.2023.171146_bib14","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1677\/joe.0.1410473","article-title":"A monoclonal antibody to C-type natriuretic peptide--preparation and application to radioimmunoassay and neutralization experiment","volume":"141","author":"Hama","year":"1994","journal-title":"J. Endocrinol."},{"issue":"5","key":"10.1016\/j.peptides.2023.171146_bib15","first-page":"L996","article-title":"Expression of C-type natriuretic peptide during development of rat lung","volume":"277","author":"Nakanishi","year":"1999","journal-title":"Am. J. Physiol."},{"issue":"6","key":"10.1016\/j.peptides.2023.171146_bib16","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1210\/en.2003-0128","article-title":"Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts","volume":"144","author":"Horio","year":"2003","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.peptides.2023.171146_bib17","doi-asserted-by":"crossref","first-page":"F464","DOI":"10.1152\/ajprenal.00372.2001","article-title":"CNP production in the kidney and effects of protein intake restriction in nephrotic syndrome","volume":"283","author":"Cataliotti","year":"2002","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"14","key":"10.1016\/j.peptides.2023.171146_bib18","doi-asserted-by":"crossref","first-page":"10729","DOI":"10.1016\/S0021-9258(17)34119-4","article-title":"Autocrine regulation of rat chondrocyte proliferation by natriuretic peptide C and its receptor, natriuretic peptide receptor-B","volume":"269","author":"Hagiwara","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"5002","key":"10.1016\/j.peptides.2023.171146_bib19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1126\/science.1672777","article-title":"Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP)","volume":"252","author":"Koller","year":"1991","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.peptides.2023.171146_bib20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s007740200048","article-title":"Significance of C-type natriuretic peptide (CNP) in endochondral ossification: analysis of CNP knockout mice","volume":"20","author":"Komatsu","year":"2002","journal-title":"J. Bone Min. Metab."},{"issue":"1","key":"10.1016\/j.peptides.2023.171146_bib21","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1006\/bbrc.1993.1616","article-title":"C-type natriuretic peptide inhibits intimal thickening after vascular injury","volume":"193","author":"Furuya","year":"1993","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.peptides.2023.171146_bib22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.lfs.2018.08.031","article-title":"C-type natriuretic peptide (CNP) in endothelial cells attenuates hepatic fibrosis and inflammation in non-alcoholic steatohepatitis","volume":"209","author":"Bae","year":"2018","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.peptides.2023.171146_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10240-1","article-title":"Overexpression of C-type natriuretic peptide in endothelial cells protects against insulin resistance and inflammation during diet-induced obesity","volume":"7","author":"Bae","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.peptides.2023.171146_bib24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bbrc.2007.02.085","article-title":"CNP infusion attenuates cardiac dysfunction and inflammation in myocarditis","volume":"356","author":"Obata","year":"2007","journal-title":"Biochem Biophys. Res Commun."},{"issue":"1","key":"10.1016\/j.peptides.2023.171146_bib25","article-title":"C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice","volume":"17","author":"Kimura","year":"2016","journal-title":"Respir. Res."},{"issue":"3","key":"10.1016\/j.peptides.2023.171146_bib26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/labinvest.2014.149","article-title":"Exogenous C-type natriuretic peptide infusion ameliorates unilateral ureteral obstruction-induced tubulointerstitial fibrosis in rats","volume":"95","author":"Hu","year":"2015","journal-title":"Lab. Investig."},{"issue":"1","key":"10.1016\/j.peptides.2023.171146_bib27","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/art.38199","article-title":"Protective effects of C-type natriuretic peptide on linear growth and articular cartilage integrity in a mouse model of inflammatory arthritis","volume":"66","author":"B\u00fck\u00fclmez","year":"2014","journal-title":"Arthritis Rheumatol."},{"issue":"10","key":"10.1016\/j.peptides.2023.171146_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/nu9101072","article-title":"Animal models of nonalcoholic fatty liver disease-a starter's guide","volume":"9","author":"Van Herck","year":"2017","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.peptides.2023.171146_bib29","doi-asserted-by":"crossref","first-page":"G483","DOI":"10.1152\/ajpgi.00079.2013","article-title":"Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment","volume":"305","author":"Clapper","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"4","key":"10.1016\/j.peptides.2023.171146_bib30","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1159\/000045836","article-title":"C-type natriuretic peptide inhibits proliferation and monocyte chemoattractant Protein-1 secretion in cultured human mesangial cells","volume":"86","author":"Osawa","year":"2000","journal-title":"Nephron"},{"issue":"4","key":"10.1016\/j.peptides.2023.171146_bib31","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1053\/j.ajkd.2014.05.019","article-title":"CKD and nonalcoholic fatty liver disease","volume":"64","author":"Targher","year":"2014","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.peptides.2023.171146_bib32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2147\/CEG.S226130","article-title":"Nonalcoholic fatty liver disease and chronic kidney disease: a review of links and risks","volume":"Volume 14","author":"Cheung","year":"2021","journal-title":"Clin. Exp. Gastroenterol."},{"issue":"1","key":"10.1016\/j.peptides.2023.171146_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-20469-z","article-title":"Adipocyte-specific expression of C-type natriuretic peptide suppresses lipid metabolism and adipocyte hypertrophy in adipose tissues in mice fed high-fat diet","volume":"8","author":"Bae","year":"2018","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.peptides.2023.171146_bib34","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1292\/jvms.19-0320","article-title":"Comparison of glucose tolerance between wild-type mice and mice with double knockout of neuromedin U and neuromedin S","volume":"81","author":"Ensho","year":"2019","journal-title":"J. Vet. Med. Sci."},{"issue":"7","key":"10.1016\/j.peptides.2023.171146_bib35","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1292\/jvms.17-0006","article-title":"Sex difference of hyperinsulinemia in the C57BL\/6J-Daruma (obese) mouse","volume":"79","author":"Suzuki","year":"2017","journal-title":"J. Vet. Med. Sci."},{"issue":"11","key":"10.1016\/j.peptides.2023.171146_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/nu11112709","article-title":"Reduced oxidative stress and enhanced FGF21 formation in livers of endurance-exercised rats with diet-induced NASH","volume":"11","author":"Henkel","year":"2019","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.peptides.2023.171146_bib37","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.3892\/ol.2017.6595","article-title":"Atypical chronic myeloid leukemia with isochromosome (X)(p10): a case report","volume":"14","author":"Yamamoto","year":"2017","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.peptides.2023.171146_bib38","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jacc.2004.10.067","article-title":"C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction","volume":"45","author":"Soeki","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"issue":"34","key":"10.1016\/j.peptides.2023.171146_bib39","doi-asserted-by":"crossref","first-page":"23761","DOI":"10.1074\/jbc.274.34.23761","article-title":"Biological effects of C-type natriuretic peptide in human myofibroblastic hepatic stellate cells","volume":"274","author":"Tao","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.peptides.2023.171146_bib40","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.lfs.2014.09.023","article-title":"C-type natriuretic peptide ameliorates ischemia\/reperfusion-induced acute kidney injury by inhibiting apoptosis and oxidative stress in rats","volume":"117","author":"Jin","year":"2014","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.peptides.2023.171146_bib41","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jhep.2020.01.013","article-title":"NAFLD as a driver of chronic kidney disease","volume":"72","author":"Byrne","year":"2020","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.peptides.2023.171146_bib42","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41581-021-00519-y","article-title":"Association of metabolic dysfunction-associated fatty liver disease with kidney disease","volume":"18","author":"Wang","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"issue":"7","key":"10.1016\/j.peptides.2023.171146_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001680","article-title":"Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis","volume":"11","author":"Musso","year":"2014","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.peptides.2023.171146_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0959-9673.2006.00465.x","article-title":"Mouse models in non-alcoholic fatty liver disease and steatohepatitis research","volume":"87","author":"Anstee","year":"2006","journal-title":"Int. J. Exp. Pathol."},{"issue":"8","key":"10.1016\/j.peptides.2023.171146_bib45","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrneph.2016.75","article-title":"Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis","volume":"12","author":"D'Agati","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"issue":"3","key":"10.1016\/j.peptides.2023.171146_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0265461","article-title":"Steatosis is involved in the progression of kidney disease in a high-fat-diet-induced non-alcoholic steatohepatitis mouse model","volume":"17","author":"Hamada","year":"2022","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.peptides.2023.171146_bib47","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00424-022-02774-9","article-title":"Localization of natriuretic peptide receptors A, B, and C in healthy and diseased mouse kidneys","volume":"475","author":"Heinl","year":"2023","journal-title":"Pfl\u00fcg. Arch. Eur. J. Physiol."},{"issue":"5","key":"10.1016\/j.peptides.2023.171146_bib48","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00280-015-2734-7","article-title":"Protective effects of C-type natriuretic peptide on cisplatin-induced nephrotoxicity in mice","volume":"75","author":"Kimura","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"6","key":"10.1016\/j.peptides.2023.171146_bib49","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1210\/endo.133.6.8243333","article-title":"Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells\u2014evidence for CNP as a novel autocrine\/paracrine regulator from endothelial cells","volume":"133","author":"Suga","year":"1993","journal-title":"Endocrinology"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978123002115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978123002115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:35:08Z","timestamp":1759311308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978123002115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":49,"alternative-id":["S0196978123002115"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2023.171146","relation":{},"ISSN":["0196-9781"],"issn-type":[{"type":"print","value":"0196-9781"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vascular endothelial cell-specific overexpression of CNP did not improve liver fibrosis in HFFCD-induced NASH, but did improve renal lesions","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2023.171146","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"171146"}}